IRMD

IRADIMED CORPORATION

IRMD · CIK 1325618 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$73M
20172024
Net Income$19M
20172024
Operating CF$26M
20172024
Free Cash Flow$18M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$0.0B$0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B$0.0B
Net Income$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
EPS (Basic)$1.52$1.36$1.02$0.76$0.11$0.85$0.59$0.05
EPS (Diluted)$1.50$1.35$1.02$0.74$0.11$0.78$0.52$0.04

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Current Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Cash & Equivalents$0.1B$0.0B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
← Companies